Patent 9034867 was granted and assigned to Alkermes (company) on May, 2015 by the United States Patent and Trademark Office.
The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.